Fort Deterick, MDNCT03609398Now EnrollingIRB Ready

Rift Valley Fever Clinical Trial in Fort Deterick, MD

Access cutting-edge rift valley fever treatment through this phase 2 clinical trial at a research site in Fort Deterick. Study-provided care at no cost to qualified participants.

Sponsored by U.S. Army Medical Research and Development Command

Quick Self-Assessment

See if you qualify for this Fort Deterick location

Preparing your pre-screening questions…

Expert Care in Fort Deterick

Access rift valley fever specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related rift valley fever treatment provided free

Apply for This Fort Deterick Location

Check if you qualify for this rift valley fever clinical trial in Fort Deterick, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fort Deterick

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fort Deterick site if eligible
  4. 4Begin participation

About This Rift Valley Fever Study in Fort Deterick

This study is to collect safety and immunogenicity data for an Rift Valley Fever (RVF) vaccine

Sponsor: U.S. Army Medical Research and Development Command

Who Can Participate

Inclusion Criteria

Be 18 to 65 years old at time of consent.
Have RVF plaque reduction neutralization 80% titers (PRNT80) \<1:10 for primary series.
Have RVF PRNT80 (plaque reduction neutralization 80% titer) \<1:40 for booster series.
If female of childbearing potential, must agree to have a urine pregnancy test on the same day before each vaccine administration. (Exception: documented hysterectomy or ≥3 years of menopause.) The results must be negative. Females must agree not to become pregnant for 3 months after receipt of the last study treatment (vaccination).
Be considered at risk for exposure to RVF virus and who have submitted a Request for IND Vaccines for the RVF vaccine.
Sign and date the approved informed consent document and HIPAA Authorization.
Have in their charts:
medical history (including concomitant medications) within 60 days of planned first administration of vaccine
physical examination and laboratory tests within 1 year
previous chest radiograph results and electrocardiogram
Be medically cleared for participation by an investigator. (Examinations and/or tests may be repeated at the discretion of the PI.)
Be willing to return for all follow-up visits.
Agree to report any adverse events (AEs) that may or may not be associated with administration of the vaccine for at least 28 days after administration and agree to report all serious adverse events (for example, resulting in hospitalization) for the duration of the subject's participation in the study.
Agree to defer blood donation for 1 year after receipt of the vaccine

Exclusion Criteria

Have completed previous RVF vaccine study as a nonresponder (PRNT80 \<1:40).
Have clinically significant abnormal laboratory results (including evidence of hepatitis C, hepatitis B carrier state) or elevated liver function tests (two times the normal range or at the discretion of the PI).
Have a personal history of an immunodeficiency or received treatment with an immunosuppressive medication, such as systemically administered glucocorticoids (eg prednisone) within 1 month before planned administration of the vaccine or with other immunosuppressive therapies within 6 months of planned administration of the vaccine. Other immunosuppressive therapies include all cancer chemotherapeutic agents, drugs to prevent transplant rejection, interferons, monoclonal antibodies, protein kinase inhibitors, methotrexate, TNF (tumor necrosis factor) inhibitors, and any other drug determined to be immunosuppressive by the PI. Current administration of topical, inhalational, or intranasal glucocorticoids is not excluded.
Have confirmed HIV infection.
Have positive pregnancy test or be breastfeeding female.
Have any known allergies to components of the vaccine:
Fetal rhesus monkey lung cells
Formaldehyde
Neomycin sulfate
Streptomycin
Sodium bisulfite
Human serum albumin (HAS)
RVF virus (Entebbe strain)
Have administration of another vaccine or investigational product within 28 days of RVF vaccination.
Have any unresolved AE resulting from a previous immunization.
Have a medical condition that, in the judgment of the PI, would impact subject safety.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fort Deterick?

Yes, this clinical trial (NCT03609398) has an active research site in Fort Deterick, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Rift Valley Fever Treatment Options in Fort Deterick, MD

If you're searching for rift valley fever treatment options in Fort Deterick, MD, this clinical trial (NCT03609398) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fort Deterick research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced rift valley fever specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all rift valley fever clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Fort Deterick, MD

See all leukemia clinical trials recruiting in Fort Deterick — not just this study.

Browse Leukemia Trials in Fort Deterick →

Browse More Trials by Condition

Leukemia TrialsAll Conditions →

Ready to Join in Fort Deterick?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fort Deterick, MD